Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Neurology|May 28, 2021
Expanding the clinical and neuroimaging features of post-varicella arteriopathy of childhoodMarta Bertamino, Sara Signa, Marco Veneruso, et al.
Clinical Immunology (Orlando, Fla.)|August 29, 2021
Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD)Riccardo Papa, Marta Rusmini, Francesca Schena, et al.
European Journal of Immunology|July 25, 2020
Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patientsFrancesca Schena, Federica Penco, Stefano Volpi, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2022
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatmentArinna Bertoni, Federica Penco, Hilaria Mollica, et al.
Journal of Clinical Immunology|June 15, 2025
NET Proteomic Profiling Reveals New Pathways Potentially Implicated in Dendritic Cell-Mediated Inflammation in DADA2 PatientsSara Signa, Martina Bartolucci, Martina Bonacini, et al.
Frontiers in Immunology|July 2, 2021
Thymic Epithelial Cell Alterations and Defective Thymopoiesis Lead to Central and Peripheral Tolerance Perturbation in MHCII DeficiencyFrancesca Ferrua, Ileana Bortolomai, Elena Fontana, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2020
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortalityVassilios Lougaris, Annarosa Soresina, Manuela Baronio, et al.
Research Square|April 20, 2022
Notch1-CD22-Dependent Immune Dysregulation in the SARS-CoV2-Associated Multisystem Inflammatory Syndrome in ChildrenTalal A Chatila, Mehdi Benamar, Qian Chen, et al.
The Journal of Clinical Investigation|October 25, 2022
The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in childrenMehdi Benamar, Qian Chen, Janet Chou, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2015
HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritisMichael J Ombrello, Elaine F Remmers, Ioanna Tachmazidou, et al.
Pageof 4